Krause was brought in as CEO for Citrix in 2022 where he established his formidable reputation as a hatchet man, laying off thousands of employees to haul the company out of its $15 billion of ...

The international controversy surrounding a standardized definition of antisemitism has reached Foggy Bottom’s doorstep, but experts in Jewish studies and the Israeli-Palestinian conflict are split on ...

Zdenyek the Mouth is full of tales and if you head over for a chat in Tachov, he’ll recount a story involving two brothers and a mysterious silver axe hidden somewhere in the Trosky Region.

This is the chilling moment a man tells police "I think I've killed an ex-partner and they're looking for me" - after he attacked his ex-girlfriend with an axe in broad daylight. Aerial helicopter ...

Britain’s biggest offshore wind developer has replaced its chief executive as the global shift to net zero falters. Ørsted, which operates 12 offshore wind farms across the UK and has four more ...

Camping axes are all designed to do one thing: make wood smaller. Whether they do it by felling a tree, delimbing, splitting, or shaping, an ax needs to efficiently break down wood. As someone who ...

The Student Association will appoint a commission to research the possible separation of the SA into graduate and undergraduate bodies, after students voted 933-206 to support the referendum to split ...

Split Fiction has gone gold, signaling the final stages of development before the title's March 6 release. The game is the latest project from Hazelight Studios, known for its work on It Takes Two ...

Egberts collected over 850 artifacts, ranging from very old hand axes from the Early or Old Paleolithic to Levallois reduction flakes from the Middle Paleolithic, all surface material.

Unlike so many game releases these days, Split Fiction is only available in a standard edition. There are no pricier versions offering digital trinkets to tempt you. However, there is one retailer ...

BioAge Labs has given up on its lead obesity candidate. Weeks after stopping a trial in response to phase 2 data, the biotech has jettisoned the molecule and shifted its focus to a preclinical ...